English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Metabolic Reprogramming Induced by Aging Modifies the Tumor Microenvironment Journal article
Chen, Xingyu, Wang, Zihan, Zhu, Bo, Deng, Min, Qiu, Jiayue, Feng, Yunwen, Ding, Ning, Huang, Chen. Metabolic Reprogramming Induced by Aging Modifies the Tumor Microenvironment[J]. Cells, 2024, 13(20), 1721.
Authors:  Chen, Xingyu;  Wang, Zihan;  Zhu, Bo;  Deng, Min;  Qiu, Jiayue; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.1/6.0 | Submit date：2024/11/05
Metabolic Reprogramming  Aging  Metabolic Plasticity  Tumor Immune Microenvironment  Pan-cancer  Glioma  Scrna Sequencing Analysis  
Metal-Phenolic Nanomedicines Regulate T-Cell Antitumor Function for Sono-Metabolic Cancer Therapy Journal article
Yan, Jie, Li, Wenxi, Tian, Hao, Li, Bei, Yu, Xinying, Wang, Guohao, Sang, Wei, Dai, Yunlu. Metal-Phenolic Nanomedicines Regulate T-Cell Antitumor Function for Sono-Metabolic Cancer Therapy[J]. ACS Nano, 2023, 17(15), 14667-14677.
Authors:  Yan, Jie;  Li, Wenxi;  Tian, Hao;  Li, Bei;  Yu, Xinying; et al.
Favorite | TC[WOS]:25 TC[Scopus]:27  IF:15.8/16.2 | Submit date：2023/09/04
Ctla-4 Blockade  Mitochondrial Dysfunction  Sono-metabolic Therapy  Treg Cell Destabilization  Tme Reprogramming  
Anticancer effects of some novel dichloroacetophenones through the inhibition of pyruvate dehydrogenase kinase 1 Journal article
Zhang, Shao-Lin, Yang, Zheng, Hu, Xiaohui, Chakravarty, Harapriya, Tam, Kin Yip. Anticancer effects of some novel dichloroacetophenones through the inhibition of pyruvate dehydrogenase kinase 1[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 123, 43-55.
Authors:  Zhang, Shao-Lin;  Yang, Zheng;  Hu, Xiaohui;  Chakravarty, Harapriya;  Tam, Kin Yip
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:4.3/4.2 | Submit date：2018/10/30
Dichloroacetophenone  Pyruvate Dehydrogenase Kinase  Pyruvate Dehydrogenase Complex  Anticancer Activity  Metabolic Reprogramming  
Deciphering the metabolic role of AMPK in cancer multi-drug resistance Journal article
Wen Tan, Zhangfeng Zhong, Randy P. Carney, Yongfan Men, Jiannan Li, Tingrui Pan, Yitao Wang. Deciphering the metabolic role of AMPK in cancer multi-drug resistance[J]. SEMINARS IN CANCER BIOLOGY, 2018, 56, 56-71.
Authors:  Wen Tan;  Zhangfeng Zhong;  Randy P. Carney;  Yongfan Men;  Jiannan Li; et al.
Favorite | TC[WOS]:32 TC[Scopus]:35  IF:12.1/13.2 | Submit date：2020/03/27
Ampk  Metabolic Reprogramming  Multi-drug Resistance  Cancer  
The typical metabolic modifiers conferring improvement in cancer resistance Journal article
Tan,Wen, Zhong,Zhangfeng, Wang,Shengpeng, Liu,Hui, Yu,Hua, Tan,Rui, Hu,Xiaodong, Pan,Tingrui, Wang,Yitao. The typical metabolic modifiers conferring improvement in cancer resistance[J]. Current Medicinal Chemistry, 2017, 24(34), 3698-3710.
Authors:  Tan,Wen;  Zhong,Zhangfeng;  Wang,Shengpeng;  Liu,Hui;  Yu,Hua; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11  IF:3.5/4.0 | Submit date：2021/03/02
2-deoxy-dglucose  3-bromopyruvate  Cancer Metabolic Reprogramming  Cancer Resistance  Lonidamine  Metabolic Modifiers  
Associations among Metabolism, Circadian Rhythm and Age-Associated Diseases Journal article
Cao, Yiwei, Wang, Rui-Hong. Associations among Metabolism, Circadian Rhythm and Age-Associated Diseases[J]. AGING AND DISEASE, 2017, 8(3), 314-333.
Authors:  Cao, Yiwei;  Wang, Rui-Hong
Favorite | TC[WOS]:17 TC[Scopus]:16  IF:7.0/7.1 | Submit date：2018/10/30
Age-associated Diseases  Circadian Rhythm  Metabolic Reprogramming  Sirtuin  Tumorigenesis  Warburg Effect  
The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance Journal article
Tan, Wen, Zhong, Zhangfeng, Wang, Shengpeng, Liu, Hui, Yu, Hua, Tan, Rui, Hu, Xiaodong, Pan, Tingrui, Wang, Yitao. The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance[J]. CURRENT MEDICINAL CHEMISTRY, 2017, 24(34), 3698-3710.
Authors:  Tan, Wen;  Zhong, Zhangfeng;  Wang, Shengpeng;  Liu, Hui;  Yu, Hua; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11  IF:3.5/4.0 | Submit date：2018/10/30
Cancer Resistance  Cancer Metabolic Reprogramming  Metabolic Modifiers  Lonidamine  2-deoxy-d-glucose  3-bromopyruvate